http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Soluna Announces Monthly Business Update
-
Biz2Credit's Annual Top 25 Cities for Small Business Report Identifies Worcester, MA as #1
-
Predictmedix AI to Headline Exclusive European Investor Roadshow Across Budapest, Zagreb, and Belgrade
-
Edthena Named One of the 'World's Top EdTech Companies' by TIME Magazine and Statista
-
Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins (IDPs) and Advance Small-Molecule Therapeutics at Scale
-
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
-
Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
-
Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
BlackSky Reports First Quarter 2025 Results
-
Stratasys Releases First Quarter 2025 Financial Results
-
Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems
-
Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
-
Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Viatris Inc (VTRS) Reports Positive Results from Phase 3 Study of Investigational XULANE LO Low Dose Patch
-
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto
-
Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential
-
Viatris Inc (VTRS) Reports Positive Top-Line Results from Two Pivotal Phase 3 Studies of MR-107A-02
-
Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
-
Digital Investment Milestone: Pakistan Becomes First to Host DCO's DFDI Forum
-
SourceAmerica highlights exceptional leadership in disability employment at 2025 Xforce Conference
-
Gogoro Releases First Quarter 2025 Financial Results
-
EU DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages enCore Energy Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 13 Deadline in Securities Class Acti
-
ADTRAN Holdings, Inc. reports preliminary first quarter 2025 financial results
-
TOP RANKED ROSEN LAW FIRM Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZYXI
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
-
ROSEN, A LEADING AND RANKED FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
ROSEN, A LEADING LAW FIRM, Encourages Ultra Clean Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UCTT
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI
-
ROSEN, A TOP RANKED LAW FIRM, Encourages The Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TBBK
-
The Future Is Golden at Grey Fox
-
Onyx Arranges $3 Million Investment by Strategic Investor and Concurrent $5 Million Bought Deal Financing
-
Tantalus Systems Holding Inc. Reports First Quarter 2025 Financial Results
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ibotta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBTA
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages XP Inc. Investors to Inquire About Securities Class Action Investigation - XP
-
Trinseo Reports First Quarter 2025 Financial Results and Provides Second Quarter Outlook
-
nuEra Cannabis Introduces “Midweek Friday Happy Hour” High-Dose THC Gummies and Beverages Redefine the After-Work Wind-Down
-
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
DLCG Announces Solid First Quarter Results with 46% Year-Over-Year Growth in Funded Mortgage Volumes to $16.4 Billion
-
Sokoman Minerals Corp. Closes First Tranche of Critical Mineral Flow-Through Private Placement
-
Atmos Energy Corporation Reports Earnings for Fiscal 2025 Second Quarter; Raises Fiscal 2025 Guidance
-
Greenberg Traurig Named Life Sciences Patent Strategy Firm of the Year
-
Ispire Technologies Inc. Schedules Fiscal Third Quarter 2025 Earnings Conference Call
-
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
-
Atmos Energy Declares Regular Quarterly Dividend
-
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NSSC
-
Consumer Cellular Selects Amdocs connectX (DOX) to Accelerate Launch of New Services
-
Consumer Cellular Selects Amdocs connectX to Accelerate Launch of New Services
-
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Firsthand Technology Value Fund, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SVVC

